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Abstract
Background: Online information retrieval systems have the potential to improve patient care but
there are few comparative studies of the impact of online evidence on clinicians' decision-making
behaviour in routine clinical work.
Methods/design: A randomized controlled parallel design is employed to assess the effectiveness
of an online evidence retrieval system, Quick Clinical (QC) in improving clinical decision-making
processes in general practice. Eligible clinicians are randomised either to receive access or not to
receive access to QC in their consulting rooms for 12 months. Participants complete pre- and post
trial surveys.
Two-hundred general practitioners are recruited. Participants must be registered to practice in
Australia, have a computer with Internet access in their consulting room and use electronic
prescribing. Clinicians planning to retire or move to another practice within 12 months or
participating in any other clinical trial involving electronic extraction of prescriptions data are
excluded from the study.
The primary end-points for the study is clinician acceptance and use of QC and the resulting change
in decision-making behaviour. The study will examine prescribing patterns related to frequently
prescribed medications where there has been a recent significant shift in recommendations
regarding their use based upon new evidence. Secondary outcome measures include self-reported
changes in diagnosis, patient education, prescriptions written, investigations and referrals.
Discussion: A trial under experimental conditions is an effective way of examining the impact of
using QC in routine general practice consultations.
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Background
Several studies have shown that clinicians have many
unanswered questions during clinical encounters which
may impact on the quality and outcomes of decisions
made. Depending on measurement techniques used to
estimate the frequency of questions and the clinical set-
ting, clinicians have anywhere between 1 and 6 questions
per patient encounter and answers are pursed for only
about 30% to 55% of questions [1-4]. Improving access to
clinical evidence through the implementation of evidence
retrieval systems is one way of supporting information
seeking in routine care [5]. Easy access to up-to-date evi-
dence at the point of care may be more effective than
other interventions aimed at improving clinicians adop-
tion of evidence-based practice such as CME, distribution
of clinical guidelines, clinical detailing, etc.
The effect of implementing information retrieval technol-
ogy in routine clinical settings and its impact on clini-
cians' decision-making has not been extensively
investigated. A 2005 review found that on average one in
three searches for information were associated with a pos-
itive impact on decision-making, however in 73% (19 of
26) of the studies examined in this review, the impact was
self-reported by clinicians using the system [6]. Assess-
ments of evidence retrieval systems have relied principally
on post study surveys. Only a small number have directly
measured use in clinical settings and in most cases pat-
terns of searching and clinical usefulness of information
retrieved could not be identified.
There are few comparative studies of online evidence
retrieval technology in routine clinical settings. A Finnish
study found no difference in compliance with recommen-
dations between computerised and paper-based clinical
guidelines among newly qualified physicians [7]. In
another study involving fourth year medical students, par-
ticipants reported that access to information on a hand-
held computer encouraged use of information, improved
learning and increased confidence in decision-making [8].
However, the effect of information retrieval technology
on clinicians decision-making process and impact upon
patient outcomes has not been assessed.
We are conducting a randomised controlled trial (RCT) to
investigate the effectiveness of an information retrieval
system called Quick Clinical (QC) in general practice [9].
The feasibility of the QC system was demonstrated in a
previous clinical trial, detailed results of this study are
reported in a separate paper [10]. Overall, 193 clinicians
used the online evidence system to conduct on average 8.7
searches per month. The majority of these searches were
conducted from consulting rooms (81%) during office
hours. The most frequent searches conducted related to
questions about diagnosis (40%) and treatment (35%).
Search subjects included a broad spectrum of diseases,
including common conditions such as asthma, diabetes
and hypertension. In this paper we describe the design
and proposed analysis of an RCT to evaluate the effective-
ness of using QC in routine general practice consultations.
Methods
Study aims
The aim of this trial is to assess the effectiveness of an
online evidence retrieval system (QC) in improving clini-
cal decision-making processes in general practice.
The specific hypotheses to be tested in this study are that:
1. Online evidence systems are clinically acceptable and
will be used by clinicians in 'real world' general practice
settings.
2. Online evidence systems are effective in changing clin-
ical decision-making behaviour and result in measurable
improvements in evidence-based prescribing decisions.
Study design and setting
A randomized controlled parallel design is used to evalu-
ate the effectiveness of QC.
Intervention
Participants are randomised to receive access to QC in
their practice for 12 months. The system is available from
a standard web browser e.g. Microsoft Internet Explorer,
Firefox etc. (Figure 1). Each user has a personal username
and password and completes an online tutorial about
how to use the system. QC is based on the generic use of
search filters specifically designed around the information
needs of general practitioners (GP). Five types of search
filters or "profiles" are available (disease aetiology, diag-
nosis, treatment, prescribing and patient education). Up
to four keywords can be used to describe a clinical ques-
tion. Clinicians search for information firstly by selecting
a search filter to match their question type (e.g. diagnosis,
treatment etc.) and then entering keywords to describe the
query. For example, a clinician who encounters a 32-year
old woman with a fourth presentation of pelvic pain in
the last 6 months with ultrasound and swabs for infection
all negative, may have a question regarding the social, psy-
chological as well as biological causes of pelvic pain. The
clinician could select the 'etiology' profile and enter 'pel-
vic pain', 'pathology' and 'psychosocial' as keywords (Fig-
ure 1). The search filters retrieve evidence from resources
including Therapeutic Guidelines (a summarised evi-
dence resource developed by Australian experts); the
Merck Manual; Health Insite (a government funded
health database); PubMed; MIMS (a pharmaceutical data-
base); and a collection of relevant Australian guidelinesBMC Medical Informatics and Decision Making 2006, 6:33 http://www.biomedcentral.com/1472-6947/6/33
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identified by a panel of clinical experts. Users can also
search each of these resources individually.
Outcomes
The primary outcome measures are clinician acceptance
and use of QC and the resulting change in decision-mak-
ing behaviour. The data from our pilot study of QC
involving 227 GPs showed that online evidence was
sought in relation to both frequent and rare clinical con-
ditions across a broad range of clinical areas [10]. This
suggests that we are likely to see access to evidence having
a broad impact across common and rare clinical deci-
sions. The RCT will therefore examine prescribing patterns
related to frequently prescribed medications where there
has been a recent significant shift in recommendations
regarding their use based upon new evidence. Examining
the effect on management decisions in clinical areas
where there is shifting evidence enables a hypothesis
driven approach to determine the impact of online evi-
dence on clinician behaviour.
The RCT will therefore focus on the changes in clinicians'
prescribing patterns in Australian National Health priority
areas identified by a panel of experts including chief inves-
tigators, associate investigators and general practitioners
(Table 1). Non-pharmacological clinical management in
these priority areas will also be examined e.g. referral for
podiatry (diabetes management), spirometry (asthma),
HbA1c testing (diabetes), cognitive behavioural therapy
(CBT) for depression, dieticians for lipid disorder. In
addition to changes in priority areas, prescribing patterns
in response to new evidence of the effectiveness of new or
existing treatments identified through reviews of literature
and expert input will also be assessed. Secondary outcome
Quick Clinical user interface Figure 1
Quick Clinical user interface.BMC Medical Informatics and Decision Making 2006, 6:33 http://www.biomedcentral.com/1472-6947/6/33
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measures to determine impact on decision-making behav-
iour include self-reported changes in diagnosis, patient
education, prescriptions, investigations and referrals.
Ethical considerations
Ethical approval for the study was obtained from the Uni-
versity of New South Wales's Human Research Ethics
Committee and subsequently ratified by Sydney Univer-
sity and the Royal Australian College of General Practi-
tioners ethics committees.
The study is also recognised by the Royal Australian Col-
lege of General Practitioners (RACGP) for its continuing
medical education (CME) program. Education points are
not directly linked to participants' use of QC, but to trial
completion.
Identification of eligible general practitioners
GPs who had a computer with Internet access in their con-
sulting rooms and used electronic prescribing are
recruited via a call for volunteers advertised in journals,
newsletters and a clinician list-server. An overview of the
trial process is shown in Figure 3. Volunteers are asked to
register via a web page and to complete a short survey to
determine their eligibility to participate in the study. The
online registration gathers baseline data about the demo-
graphics of the sample including practice characteristics
and computer use [see Additional file 1]. Eligibility and
exclusion criteria are listed in Table 2. To participate in the
study clinicians must be registered to practice in Australia;
have a computer with Internet connectivity; and prescribe
electronically. GPs who are planning to retire or move to
another practice within 12 months or participating in
other concurrent trials involving electronic extraction of
prescription data are excluded from the study.
Eligible GPs are randomly allocated to either the control
or intervention group, each clinician is given a unique
study identification code and the web address of QC is
sent to eligible participants one week prior to commence-
ment of the trial. Participants visiting the QC web site are
given detailed information about the trial along with the
participant information statement and the consent form.
A revocation of consent form is also available online. Cli-
nicians willing to participate complete the online consent
form and a pre-trial survey which assesses information
seeking habits and attitudes to information seeking dur-
ing consultations [see Additional file 2]. A psychometric
instrument used to classify clinicians' response styles to
new information as seekers, receptives, traditionalists, or
pragmatists is also administered as part of the pre-trial sur-
vey [see Additional file 3] [11].
Data collection
The timing and content of study assessments are summa-
rised in Table 5. Frequency and purpose of system use of
QC are determined from automatically generated compu-
ter logs used to record details of each search including the
search filter chosen, keywords entered, data sources
accessed, user IP (Internet Protocol) address, date, time
and duration of searches [see Additional file 4]. Users are
asked to identify if the IP address is their home or consult-
ing room. An online feedback facility within the QC user
interface is used to record clinicians comments in context
of specific searches that generate the feedback (Figure 2).
Participants in both the control and intervention group
provide prescribing data in electronic format [see Addi-
tional file 5]. The data extraction process excludes all
potentially identifying information such as patient name,
address, gender, postcode, telephone number, Medicare
Table 1: Clinical priority areas used to measure primary outcomes.
Clinical area Expected changes in intervention group
Asthma ↓ short acting beta-agonists
↑ long-acting beta-agonists
↑ inhaled corticosteroids (decreased dose of steroids over time i.e. back titration or 
combinations of LABA & corticosteroids)
Depression ↑ SSRIs, ↑ SNRIs
↓ TCAs;
Hypertension ↑ diuretics
↓ other antihypertensives
Upper respiratory tract infection ↓ antibiotics and ↑ appropriate antibiotics
Immunisation/vaccination Higher rate of immunization and closer compliance with schedule.
Lipid disorders ↑ Statins,
Type 2 Diabetes ↑ glitazones ↑ metformin
↑ insulin
↓ sulfonylureas
Non-inflamatory musculoskeletal including osteoarthritis ↑ paracetamol
↓ NSAIDs
↓ Cox-2 inhibitorsBMC Medical Informatics and Decision Making 2006, 6:33 http://www.biomedcentral.com/1472-6947/6/33
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number, progress notes, images (e.g. X-rays) and any data
fields that could identify a patient, such as free text fields.
Data for the study period (i.e. 12 months retrospective
data plus 12 months of the intervention period) is elec-
tronically extracted from prescribing software using secure
means without any intrusion on clinicians' work.
Screenshot of online feedback facility (questions after [16]) Figure 2
Screenshot of online feedback facility (questions after [16]).
Table 2: Study inclusion and exclusion criteria.
Inclusion criteria
• general practitioners registered to practice in Australia
• use a computer with Internet access in consulting rooms
• use electronic prescribing
Exclusion criteria
• concurrent participation in other clinical trials involving electronic extraction of prescription data
• planning to retire or move within the next 12 monthsBMC Medical Informatics and Decision Making 2006, 6:33 http://www.biomedcentral.com/1472-6947/6/33
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The prescription data extraction software and installation
instructions are sent by email and also are made available
online. The first data extraction (i.e. retrospective prescrip-
tions data from the previous 12 months) is performed
after installation of the extraction software at the start of
the study. The second extraction is scheduled at 6 months
and the final at 12 months. An uninstall program will
remove all extraction software, created files and changes
to profiles in clinicians' prescribing software. At the end of
12 months all participants complete a post-trial survey
[see Additional file 6]. Participants attitudes to informa-
tion seeking and responses to the psychometric instru-
ment used in the pre-trial survey are repeated post-trial.
Randomisation, blinding and allocation concealment
Eligible GPs are stratified by gender and randomised to
the intervention or control group using a computer gener-
ated random number sequence in randomly assigned
blocks (max. block size 8) and online evidence allocation
ratio of 1:1. For each level of strata, a random sequence of
study group assignments is generated using a computer-
ized random-number generator [12]. Each level of strata
are numbered consecutively. Each doctor receives the next
consecutive number in his or her stratum.
Since QC is a behavioural intervention it is not possible to
blind participants to the intervention. However investiga-
tors are blinded to group assignment. The randomisation
sequence is generated and clinicians are randomly
assigned to two groups by a researcher from the Evalua-
tion team of the Centre for Health Informatics. This indi-
vidual is not directly involved in the study nor its analysis.
The group assignment is revealed to clinicians online only
after they consent to participate in the study following
completion of the pre-trial survey. To minimise contami-
Overview of trial process Figure 3
Overview of trial process.
Eligible GPs (n > 200)
Eligibility criteria
 Registered GP
 Computer with Internet
access
 Electronic prescribing
Stratified by gender and
randomised
Excluded
 planning to retire or
move within 12 months
 concurrent participation
in other trials
Allocated to Quick Clinical (n=100)
Were able to access QC (n= )
Could not access QC (n= )
Could not provide prescribing data (n= )
Lost to follow-up
Discontinued use of QC (n= )
Allocation
Follow-up
Analysed
Excluded from analysis (n= )
Analysis
Allocated to control group (n=100)
Provided prescribing data (n= )
Could not provide prescribing data (n= )
Lost to follow-up
Discontinued participation (n= )
Analysed
Excluded from analysis (n= )
EnrollmentBMC Medical Informatics and Decision Making 2006, 6:33 http://www.biomedcentral.com/1472-6947/6/33
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nation of control participants who might work closely
with practitioners who are part of the intervention group,
only one clinician is eligible to participate in the trial from
each practice. In cases where there are multiple registra-
tions from a single practice, only the first registrant is eli-
gible to participate. Participants in the intervention group
are asked not to share their QC access details with their
colleagues.
Communication with participants
Email will be the primary channel to communicate with
participants for information and reminders about:
1. start of the trial (followed up with 2 fortnightly remind-
ers)
2. instructions for installing and using prescribing data
extraction tool
3. post-trial survey
4. education points notification and summary of main
results
Subject withdrawal
Participants who formally withdraw from the study are
contacted by telephone to determine reason for with-
drawal. Similarly participants who do not use QC nor pro-
vide prescribing data are contacted to determine reasons
for not completing the study.
Sample size considerations
Sampling unit is the GP and the unit of analysis is also the
GP. We provide the following example to demonstrate
that the RCT sample size will be more than sufficient for
detecting statistically significant prescription changes in
medication areas where there is a shift in evidence. The
example used to verify the design is measuring a 10%
increase in use of preventer medications (glucocorticoid
inhaled medications) in Asthma. Currently on average,
53% of GP encounters for asthma lead to the prescription
of a preventer medication [13]. We expect that access to
QC will promote the use of preventer medication by GPs
who use the intervention. We expect that in the interven-
tion group – at least 58.4% of GP encounters for asthma
lead to the prescription of a preventer medication.
As the prescriptions belonging to the same GP will tend to
be correlated, the sample size calculations estimated the
average number of condition-specific prescriptions per GP
and adjustments were made for intracluster correlation
factor estimated to be 0.02 [14].
The number of GPs required in each arm to detect a 10%
change in average prescription rate per 100 condition-spe-
cific encounters per GP are listed in Table 4[15]. Given
Table 4: Sample size estimation (statistical power: 80% power, at the 5% significance level).
Condition Annual rate of medication use per 100 problem-
specific encounter
Sample size (no. of GPs required in each arm)
Asthma- use of preventers 53.2 54
Asthma- SA Bronchodilators 53.1 54
Depression- SSRI 41.7 85
Table 3: Timing and content of study assessments.
Identifying eligible clinicians
Trial registration: self completed online
Baseline data
Pre-trial survey: self completed online
Prescription data from previous 12 months: electronic extraction
Clinician follow-up procedures
Primary outcome measures: Computer log and electronic prescription data at 6 and12 months
• Physician acceptability focusing on ease of use and usefulness (post-trial survey) and patterns of QC use (computer logs)
• Prescribing patterns in clinical priority areas identified at the start of the study
• Prescribing patterns in response to new evidence of the effectiveness of new or existing treatments
• Patterns of non-pharmacological clinical management
Secondary outcome measures: self-reported in online post-trial survey at 12 months
• Referral patterns
• Management decisions
• Number, timing and types of investigationsBMC Medical Informatics and Decision Making 2006, 6:33 http://www.biomedcentral.com/1472-6947/6/33
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that data collection in the trial will run for a minimum of
12 months 100 GPs in each arm will be sufficient to detect
a 10% change in prescriptions (p = 0.05, power = 0.80).
Statistical analyses
All registered participants will have completed the pre-
trial survey. The subset of the intervention group analysed
for primary outcome will have completed the post-trial
survey and provided prescribing data. Participants in
intervention group who encounter technical difficulties in
using QC will be excluded from this analysis (i.e. those
who had the opportunity to use QC but did not do so will
be included). All of the control group except those who
did not provide prescribing data will be included in the
primary analysis. As summarised in Table 5 the interven-
tion and control groups will be compared for baseline dif-
ferences in prescription patterns, case-mix and profile of
participants. Using an intention to treat analysis adjusted
data will be analysed to determine differences in prescrib-
ing patterns and non-pharmacological management in
identified priority areas, and areas in which there have
been recent changes in response to new evidence using a
one-tailed binomial test for proportions. Self-reported
changes in diagnosis, patient education, prescriptions,
investigations, referrals will also be examined. Utilisation
and outcome measures will be analysed relative to QC
usage and patient load (e.g. by number of patients seen).
Time plan for the RCT of Quick Clinical
Recruitment commenced in October 2004, 203 GPs vol-
unteered to participate in the study and the trial formally
commenced in May 2005. The trial under experimental
conditions will evaluate the effectiveness of using QC in
routine general practice consultations.
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Additional material
Additional file 1
Online registration. Summary of items in online registration.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1472-
6947-6-33-S1.doc]
Additional file 2
Title: Pre-trial survey. Summary of items in online pre-trial survey.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1472-
6947-6-33-S2.doc]
Additional file 3
Physician response styles. Summary of items in online pre-trial psychomet-
ric instrument used to classify physician response styles to new information 
as seekers, receptives, traditionalists, or pragmatists.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1472-
6947-6-33-S3.doc]
Table 5: Summary of analyses for the RCT of Quick Clinical.
Analyses to determine impact of Quick Clinical on decision-making
1. Baseline comparisons between control and intervention groups (unadjusted data)
a) proportion of prescriptions by ATC* categories and in priority areas (using 12 months retrospective data)
b) case-mix (age-gender distribution of patients)
c) participants' profile (gender, age, place of graduation, geographic distribution, computer skills)
2. Interim analyses at 6 months
a) analyses of baseline prescribing data. Reports of interim analyses affecting the ongoing conduct of the trial and interpretation of final results
3. Using an intention to treat analysis (i.e. irrespective of patterns of QC use in the intervention group) we will include all participants in the primary 
analyses using adjusted data to determine:
a) broad differences in proportion of prescriptions by ATC classification
b) specific differences in proportion of prescriptions by priority area (e.g. Antibiotics prescribed for URTI)
c) differences in prescription patterns in response to new evidence of the effectiveness of new or existing treatments
d) differences in non-pharmacological treatments
e) analysis of prescription changes relative to search categories
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